Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272049 · ClinicalTrials.gov registry record · Phase 1
Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults
A Phase 1 study of Respiratory Disorders, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT02272049: Recruiting Phase 1 study of Respiratory Disorders, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02272049 is a Phase 1 study of Respiratory Disorders that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 300 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (400% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272049, a Phase 1 study of Respiratory Disorders, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the usefulness of hyperpolarized (HP) 129Xe (xenon) gas MRI for regional assessment of lung function in a normal population of children and adults and in adults and also in children with respiratory compromise due to a variety of diseases.
Primary Outcome
quantify the measurement agreement between the ventilated volume of healthy lungs predicted via 129 Xe MRI and the ventilated volume of the pleural cavity predicted via proton MRI
Conditions Studied
Interventions
- DRUG Hyperpolarized 129 Xenon
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-12 |
| Est. Completion | 2029-08-31 |
| Phase | Phase 1 |
What NCT02272049 shows while recruiting
NCT02272049 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (400% higher).
The record links to 1 condition, with Respiratory Disorders appearing as the primary indexed condition, and to 1 intervention - of which Hyperpolarized 129 Xenon is the first listed.
NCT02272049 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02272049 about?
NCT02272049 is a clinical study titled "Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults". The goal of this study is to evaluate the usefulness of hyperpolarized (HP) 129Xe (xenon) gas MRI for regional assessment of lung function in a normal population of children and adults and in adults and also in children with respiratory compromise due to a variety of diseases.
What is the current status of trial NCT02272049?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 300 participants. The study started on 2014-12. Estimated completion is 2029-08-31.
What conditions does trial NCT02272049 study?
This clinical trial studies the following conditions: Respiratory Disorders.
What interventions are being tested in trial NCT02272049?
The interventions under investigation include: Hyperpolarized 129 Xenon (DRUG).
Who is sponsoring clinical trial NCT02272049?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02272049 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02272049's enrollment target sits among peer trials
300 124th of 2000 higher than 1,867 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration
RECRUITING · Phase 1
-
A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia